BioSpace News Archive

Century Therapeutics , Inc. today reported financial results and business highlights for the second quarter ended June 30, 2022.

Wave Life Sciences Ltd. today announced financial results for the second quarter ended June 30, 2022 and provided a business update.

Enzo Biochem, Inc., a leading biosciences and diagnostics company, announced that its full-service clinical laboratory will begin accepting specimens for monkeypox testing this week.

Solid Biosciences Inc. today reported financial results for the second quarter ended June 30, 2022 and provided a business update.

Health Canada has granted a Notice of Compliance with Conditions (NOC/c) for Lynparza ® (olaparib) for the adjuvant treatment of adult patients with deleterious or suspected deleterious germline BRCA -mutated (g BRCA m),

Acacia Research Corporation (Nasdaq: ACTG) (“Acacia” or the “Company”) today reported financial results for the three and six months ended June 30, 2022.

Levita Magnetics today announced the closing of its $26 million Series C financing, which will be used to support regulatory and near-term commercial efforts in the United States for its Magnetic-Assisted Robotic Surgery (MARS) platform.

Kaléo, a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing life-transforming products for certain serious and life-threatening medical conditions, announced the appointment of a Chief Commercial Officer as well as the formation of a new Government Sector business unit.

Landos Biopharma, Inc. today announced financial results for the second quarter ended June 30, 2022, and provided a business update.

AcelRx Pharmaceuticals, Inc. today announced that an abstract, entitled, “Experience in Complex Outpatient Plastic Surgery Procedures Using Sufentanil Sublingual Tablets” has been accepted for podium presentation at Plastic Surgery: The Meeting 2022, taking place October 27-30, 2022 in Boston, MA.